Nuvation Bio NUVB
NYSE NUVB
$5.13 -0.42 (-7.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nuvation Bio (NUVB) Price to Sales (2024 - 2026)

Updated

Nuvation Bio's (NUVB) Price to Sales was 11.58 for Q2 2026, down 74.8% from 45.89 a year earlier but up 11.5% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Nuvation Bio was 49.36, down 56.8% from FY2024.

  • By year, Price to Sales came in at 114.14 in FY2024.
  • Five-year quarterly Price to Sales spans a low of 10.39 in Q1 2026 and a high of 505.91 in Q2 2024.
  • Year over year, Price to Sales has now declined in each of the last five quarters, with an average decline of 78.0% over the last five quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 10.39 (Q1 2026), 49.36 (Q4 2025) and 46.73 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Nuvation Bio 1.78 Bn 1.78 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.58
Mar 31, 2026 10.39
Dec 31, 2025 49.36
Sep 30, 2025 46.73
Jun 30, 2025 45.89
Mar 31, 2025 54.27
Dec 31, 2024 114.14
Sep 30, 2024 356.16
Jun 30, 2024 505.91
API Access

Nuvation Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NUVB&period=max&api_key=YOUR_API_KEY